![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/26 | (2006.01) |
A61P 1/00 | (2006.01) |
(11) | Number of the document | 3638291 |
(13) | Kind of document | T |
(96) | European patent application number | 18734135.9 |
Date of filing the European patent application | 2018-06-15 | |
(97) | Date of publication of the European application | 2020-04-22 |
(45) | Date of publication and mention of the grant of the patent | 2021-08-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2018/065951 |
Date | 2018-06-15 |
(87) | Number | WO 2018/229252 |
Date | 2018-12-20 |
(30) | Number | Date | Country code |
201709643 | 2017-06-16 | GB | |
201714203 | 2017-09-05 | GB | |
201800873 | 2018-01-19 | GB |
(72) |
SONNE, Kim , DK
MOURITZEN, Ulrik , DK
GLERUP, Peter , DK
JEPPESEN, Palle Bekker , DK
|
(73) |
Zealand Pharma A/S ,
Sydmarken 11, 2860 Søborg,
DK
|
(54) | DOSAGE REGIMES FOR THE ADMINISTRATION OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES |
DOSAGE REGIMES FOR THE ADMINISTRATION OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES |